Doximity Inc

DOCS

NASDAQ. Currency in USD

35.63 -0.12 ( -0.34% )

Real time prices: December 09

Market Cap.
6.86B
Beta (5Y monthly)
-
Price/Earnings
42.91
EPS (TTM)
0.81
Forward Dividend
0.00 (0.00%)
Ex-Dividend Date
Volume
1.33M
1y Target Est.
41.00
Day's Range
35.41
-
36.24
52 Week's Range
22.91
-
64.95

Historical Summary

Performance
EPS growth
Share Buybacks

About Doximity Inc

Sector
Healthcare
Industry
Health Information Services
Website
https://www.doximity.com
Exchange
NASDAQ (XNAS)
Shares Outstanding
110.47M
Employees
953
Address
500, 3rd Street, San Francisco, CA, United States, 94107
Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

Latest news

Here's Why Doximity Climbed 28% in November
Here's Why Doximity Climbed 28% in November

The telehealth company published strong earnings results and spoke favorably about its advertising business.
By The Motley Fool - 1 day ago

2 Top Growth Stocks Down 65.2% to 80.3% to Buy in December
2 Top Growth Stocks Down 65.2% to 80.3% to Buy in December

These stocks have fallen hard in 2022, but their best days are still ahead.
By The Motley Fool - 4 days ago

AMN or DOCS: Which Is the Better Value Stock Right Now?
AMN or DOCS: Which Is the Better Value Stock Right Now?

AMN vs. DOCS: Which Stock Is the Better Value Option?
By Zacks Investment Research - 1 week ago

2 Top Growth Stocks Down 42.6% and 68.5% to Buy Before They Rebound in 2023
2 Top Growth Stocks Down 42.6% and 68.5% to Buy Before They Rebound in 2023

These relatively reliable healthcare businesses are performing much better than their beaten-down stock prices would...
By The Motley Fool - 1 week ago

Why Shares of Doximity Fell This Week
Why Shares of Doximity Fell This Week

The social-media platform for healthcare professionals fell early in the week before bouncing back a...
By The Motley Fool - 1 week ago

Dr Martens shares given the boot after profit warning
Dr Martens shares given the boot after profit warning

Lower margins and a more cautious consumer leave shares well below IPO price.
By MarketWatch - 2 weeks ago

Doximity: There's Much To Be Excited About Here
Doximity: There's Much To Be Excited About Here

Doximity has seen its revenue growth rates stabilize, while it remains highly profitable. Click here...
By Seeking Alpha - 2 weeks ago

Is Doximity's Stock Still Too Expensive to Buy?
Is Doximity's Stock Still Too Expensive to Buy?

The stock still trades at close to 50 times earnings.
By The Motley Fool - 2 weeks ago